title: Sertraline in the treatment of patients with social phobia.
authors.affiliation: Department of Psychiatry, Georgetown University Medical Center, Washington, D.C. 20007, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Martins
authors.forename: T A
authors.initials: TA
authors.lastname: Pigott
authors.forename: S E
authors.initials: SE
authors.lastname: Bernstein
authors.forename: B B
authors.initials: BB
authors.lastname: Doyle
authors.forename: B
authors.initials: B
authors.lastname: Sunderland
authors.forename: V M
authors.initials: VM
authors.lastname: Smolka
authors.forename: B
authors.initials: B
authors.lastname: Dubbert
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D020280:Sertraline; D012919:Social Behavior; D016896:Treatment Outcome
chemical_list: D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline